Clinical Trial Update: Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection) [Phase 1]

View source ↗

Summary

This entry reports results from a Phase 1 trial evaluating rhIGF-1 (mecasermin [rDNA] Injection) for Rett syndrome. The study has completed, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• mecasermin (insulin-like growth factor 1)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Rett Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2017-06-22